CNS diseases
HBM contact: Dr Priyanka Belawat
Company status: private
Neurelis, Inc. is a specialty pharmaceutical company
organized to license, develop, and commercialize product candidates for the
treatment of central nervous system disorders with a focus on the treatment of
acute breakthrough seizures (epilepsy) and acute anxiety episodes.